The Concentration Monitoring of Safty for Xuesaitong TCM Injection

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-14004593

Enrollment

Unknown

Registered

2014-04-30

Start date

2014-05-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADR

Interventions

case series:Xuesaitong TCM Injection

Eligibility

Sex/Gender

All

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: all the patients who accept the treatment of Xuesaitong injection.

Exclusion criteria

Exclusion criteria: the patients who allergic to Xuesaitong injection.

Design outcomes

Primary

Measure	Time frame
Safety indexes;	—

Countries

China

Contacts

Public ContactShang hongcai

Tianjin University of TCM

shanghongcai@foxmail.com+86 18202525733

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026